- Report
- August 2025
- 182 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,029GBP
- Report
- March 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,961GBP
€4317EUR$4,850USD£3,730GBP
- Report
- February 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- August 2025
- 285 Pages
Global
From €5207EUR$5,850USD£4,499GBP
- Report
- March 2025
- 180 Pages
Global
From €4006EUR$4,500USD£3,461GBP
- Report
- May 2025
- 120 Pages
Global
From €4228EUR$4,750USD£3,653GBP
- Report
- September 2024
- 158 Pages
Global
From €2225EUR$2,500USD£1,923GBP
- Report
- July 2025
- 350 Pages
Global
From €4405EUR$4,949USD£3,806GBP
- Report
- March 2025
- 130 Pages
Global
From €3670EUR$4,123USD£3,170GBP
€4317EUR$4,850USD£3,730GBP
- Report
- August 2025
- 199 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,029GBP
- Report
- August 2025
- 183 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,029GBP
- Report
- August 2025
- 186 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,029GBP
- Report
- August 2025
- 188 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,029GBP
- Report
- August 2025
- 181 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,029GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- March 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- March 2025
- 250 Pages
Global
From €3997EUR$4,490USD£3,453GBP

The Pneumococcal Vaccine is a type of vaccine used to protect against infection caused by the bacterium Streptococcus pneumoniae. It is used to prevent a range of illnesses, including pneumonia, meningitis, and sepsis. The vaccine is typically administered to infants and young children, as well as adults who are at an increased risk of infection. It is also recommended for adults over the age of 65.
The Pneumococcal Vaccine market is a subset of the larger Vaccines market. It is a highly competitive market, with a number of companies offering different types of vaccines. These companies are typically involved in the research, development, and production of the vaccines. They also provide support services such as distribution, marketing, and education.
Some of the companies in the Pneumococcal Vaccine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more